We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
-$179M
Cap. Flow
-$339M
Cap. Flow %
-11.66%
Top 10 Hldgs %
11.95%
Holding
1,370
New
136
Increased
551
Reduced
477
Closed
195

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$15.7M
2
PM icon
Philip Morris
PM
+$13.6M
3
MO icon
Altria Group
MO
+$13.4M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.7M
5
HUBB icon
Hubbell
HUBB
+$8.92M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$61.6M
2
V icon
Visa
V
+$20.6M
3
ADBE icon
Adobe
ADBE
+$13.8M
4
ACN icon
Accenture
ACN
+$12.5M
5
PCAR icon
PACCAR
PCAR
+$9.72M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Healthcare 13.07%
3 Industrials 12.02%
4 Consumer Discretionary 10.67%
5 Financials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACGL icon
1176
Arch Capital
ACGL
$36.1B
– –
-16,679
Closed -$1.13M
ACLX
1177
DELISTED
Arcellx
ACLX
– –
-22,755
Closed -$701K
ACM icon
1178
Aecom
ACM
$9.07B
– –
-3,738
Closed -$315K
AGCO icon
1179
AGCO
AGCO
$8.78B
– –
-2,724
Closed -$368K
AGEN
1180
Agenus
AGEN
$249M
– –
-14,744
Closed -$440K
AGNC icon
1181
AGNC Investment
AGNC
$12.3B
– –
-22,429
Closed -$226K
AIZ icon
1182
Assurant
AIZ
$13.7B
– –
-3,329
Closed -$400K
ALLO icon
1183
Allogene Therapeutics
ALLO
$601M
– –
-101,213
Closed -$500K
ALLY icon
1184
Ally Financial
ALLY
$13.1B
– –
-15,990
Closed -$408K
ALV icon
1185
Autoliv
ALV
$8.6B
– –
-4,783
Closed -$447K
ARGX icon
1186
argenx
ARGX
$57.4B
– –
-2,140
Closed -$797K
OPTU
1187
Optimum Communications Inc
OPTU
$316M
– –
-14,827
Closed -$50.7K
AVT icon
1188
Avnet
AVT
$7.33B
– –
-4,662
Closed -$211K
BAM icon
1189
Brookfield Asset Management
BAM
$74B
– –
-15,894
Closed -$520K
BC icon
1190
Brunswick
BC
$5.19B
– –
-4,549
Closed -$373K
BCE icon
1191
BCE
BCE
$19.9B
– –
-18,602
Closed -$832K
BCYC
1192
Bicycle Therapeutics
BCYC
$270M
– –
-24,287
Closed -$517K
BF.B icon
1193
Brown-Forman Class B
BF.B
$12B
– –
-28,130
Closed -$1.81M
BIO icon
1194
Bio-Rad Laboratories Class A
BIO
$8.42B
– –
-1,537
Closed -$736K
BNY
1195
Bank of New York Mellon
BNY
$108B
– –
-32,386
Closed -$1.47M
BLUE
1196
DELISTED
bluebird bio
BLUE
– –
-686
Closed -$43.6K
BMO icon
1197
Bank of Montreal
BMO
$125B
– –
-8,000
Closed -$714K
BNS icon
1198
Scotiabank
BNS
$106B
– –
-19,916
Closed -$1M
BTU icon
1199
Peabody Energy
BTU
$2.78B
– –
-49,222
Closed -$1.26M
BUD icon
1200
AB InBev
BUD
$158B
– –
-4,628
Closed -$309K
46 47
48
49 50

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2023 Portfolio in Review

As of Q2 2023, Vident Investment Advisory held 1,370 positions worth $2.9B, down 5.8% from $3.08B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Vident Investment Advisory withdrew a net $339M in Q2 2023, closing 195 positions and reducing 477 holdings. Its most notable exit was Polaris, an estimated $8.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Hubbell worth $10.7M.

  • Vident Investment Advisory's largest Q2 2023 buy was Hubbell: 32,210 shares worth $10.7M.
  • Vident Investment Advisory added most to T-Mobile US in Q2 2023, an estimated $15.7M increase.
  • Vident Investment Advisory's biggest Q2 2023 reduction was Apple, cutting an estimated $61.6M.
  • Vident Investment Advisory fully exited Polaris in Q2 2023, selling an estimated $8.05M.
  • Vident Investment Advisory's ten largest holdings make up 12% of its $2.9B portfolio in Q2 2023.
  • Vident Investment Advisory opened 136 new positions and closed 195 in Q2 2023.
  • Vident Investment Advisory's portfolio value fell 5.8% quarter-over-quarter to $2.9B.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.